{"id":791,"date":"2012-04-01T12:00:00","date_gmt":"2012-04-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/verordnungen-und-preise-einiger-in-der-priscus-liste-aufgefuehrter-und-haeufig-verordneter-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2011-datenbasis-des-jahres-2010-gkv-arzneimittelin"},"modified":"2022-03-17T14:12:22","modified_gmt":"2022-03-17T13:12:22","slug":"verordnungen-und-preise-einiger-in-der-priscus-liste-aufgefuehrter-und-haeufig-verordneter-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2011-datenbasis-des-jahres-2010-gkv-arzneimittelin","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/verordnungen-und-preise-einiger-in-der-priscus-liste-aufgefuehrter-und-haeufig-verordneter-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2011-datenbasis-des-jahres-2010-gkv-arzneimittelin","title":{"rendered":"Verordnungen und Preise einiger in der PRISCUS-Liste aufgef\u00fchrter und h\u00e4ufig verordneter Arzneimittel, basierend auf dem Arzneiverordnungs-Report 2011, Datenbasis des Jahres 2010: GKV-Arzneimittelindex im WIdO. Preisstand 1. April 2012."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2071,618,2073,2072,1355,1360,10,398,994,1368,1249,628,645,2074,574,2069,2070,898,908,1350],"class_list":["post-791","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-acetyldigoxin","tag-amitriptylin","tag-azetyldigoxin","tag-bromazepam","tag-cox-2-hemmer","tag-coxibe","tag-diazepam","tag-doxazosin","tag-doxepin","tag-etoricoxib","tag-lorazepam","tag-nitrofurantoin","tag-oxazepam","tag-pentoxifyllin","tag-sotalol","tag-tetrazepam","tag-trimipramin","tag-zolpidem","tag-zopiclon","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=791"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/791\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}